Full-Time

IT Director

Global Application Development, Solution Delivery GQO

Updated on 5/12/2026

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

No salary listed

Company Historically Provides H1B Sponsorship

Jackson Township, NJ, USA

Hybrid

Category
IT & Security (1)
Required Skills
Visio
Word/Pages/Docs
Data Analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor's Degree from an accredited university in the areas of Computer Science, Engineering, Information Systems, Business, or equivalent field of study required
  • Minimum of 10-15 years of professional experience with Manufacturing (SAP ERP/MES), Product Lifecycle Management (PLM), Product Quality Systems, Supply Chain, Distribution, and Enterprise Planning and Logistics
  • Minimum of 7-10 years of large SAP ERP implementations/deployments required; SAP S4 HANA desired
  • Prior experience and demonstrated understanding of GQO or other complex business solutions with direct experience in global system rollouts required
  • Ability to work effectively in a matrix organization structure with significant emphasis on collaboration and persuasion, rather than relying entirely on command and control is required
  • Ability to maintain strong relationships within Stryker Divisions and geographies
  • Ability to consider upstream and downstream process impacts and implications
  • Exhibits acute business acumen and understanding of organizational issues and challenges
  • Versatility and willingness to work with constantly changing priorities with enthusiasm
  • Demonstrated ability to communicate effectively with Senior Management
  • Must be able to generate, explain, and present detailed schedules, objectives, reports, and other documentation accurately
  • Demonstrated ability to work cohesively across a cross functional and matrixed organization
  • Strong data analysis and problem-solving skills
  • Ability to drive initiatives and projects independently from start to finish
  • Strong knowledge of Excel Advanced, PowerPoint presentations, Word documents, Access DB, MS Project Suite (MPP/Visio/etc.)
  • Exceptional written, verbal and presentation skills to a diverse set of audiences
  • Travel Percentage: 20%
Responsibilities
  • Responsible for the delivery of GQO solutions for E2E strategic and operational business processes within GAD Manufacturing, Supply Chain, RAQAC and R&D organizations
  • Responsible for planning & managing cutover and solution delivery deliverables along with SI’s, business and PMs for approved projects within the GQO portfolio
  • Defines a deployment framework which can be leveraged across all GQO programs and projects
  • Aligns on Technical Designs, Prototypes/Mock-ups, Development, Cutover, Testing and Delivery of solutions for Release Cycles and/or new projects within the GQO application stack
  • Creates individual/custom deployment plans for each program across Stryker divisions, functions, and regions with detailed contingency plans and “Go/No Go” decision points
  • Creates, coordinates and influences the deployment communication plans, including “Go Live” readiness, change management, cutover, and stabilization
  • Works with divisional deployment leads and IT teams to manage and prepare each division for solution readiness, data cleansing, data migration and training
  • Manages and coordinates with external suppliers and deployment partners to ensure they meet their contracted deliverables, agreed upon timelines, and metrics
  • Working with PMO, Delivery Leads, Process Leads, and Change management, develop standards, tools and systems to effectively and efficiently manage the deployment of the GQO products across Stryker divisions, functions, and regions
  • Establishes deployment metrics and ensures each division, function, and region are measuring pre and post “Go Live” success metrics
  • Works closely with IT Service Delivery teams to ensure implementation of post-production support model and processes
  • Perform activities following Stryker’s Software Development Lifecycle (SDLC) framework and processes
  • Manages resolution and communication of system production support issues with different stakeholders based on Stryker SLA’s
  • Works closely with strategic solution partners, business process owners, architects/leads from other tracks and super users to close out every phase as part of deployment playbook or project methodology
  • Provide guidance and mentoring to other Solution Leads and Solution Analysts within the team or same project/program
  • Identify opportunities to improve the systems process flow, performance and technical efficiencies
  • Develop and build robust integration with Infrastructure, Security, Governance, Service Delivery, etc.
  • Financial focus on delivering activities on budget, leveraging time on value-driven activities and ensuring external resources meet contractual deliverables
  • Special projects/assignments as required
Desired Qualifications
  • Master’s degree in MIS, MBA or related disciplines preferred
  • International experience and/or exposure working in other business functions preferred
  • Knowledge of Lean, ITIL, Project Portfolio Management, Project Management Office, etc. standards and processes preferred
  • Experience in enterprise solution methodologies, preferably in both traditional waterfall and agile approaches preferred

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Simplify Jobs

Simplify's Take

What believers are saying

  • Robotic surgery leadership drives double-digit sales growth through 2025.
  • India Trident II launch targets aging population's rising hip surgeries.
  • Peripheral vascular expansion via IVL meets growing arterial disease demand.

What critics are saying

  • Handala cyberattack on March 11 delays ortho supply chain 3-6 months.
  • Zimmer Biomet Persona IQ erodes ortho share with real-time analytics.
  • J&J Velys captures 25% more knee procedures from Mako in 6-12 months.

What makes Stryker unique

  • Stryker holds 39.1% US market share in orthopedic product manufacturing.
  • Trident II Acetabular System integrates Mako SmartRobotics for hip replacements.
  • Amplitude Vascular Systems acquisition adds CO₂ IVL for peripheral arteries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Company News

ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.